Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference39 articles.
1. Nuki G, Brooks RG, Buchanan W. The economics of arthritis. Bull Rheum Dis1972;23:726–33.
2. Thompson MS, Liang MH. Examples of cost–benefit analysis: the rheumatic diseases. In: Abshagen U, Münnich FE, eds. Cost of illness and benefits of drug treatment. München: W. Zuckschwerdt, 1990:pp. 45–50.
3. Lambert CM, Hurst NP. Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol1995;34:774–80.
4. Rothfuss J, Mau W, Zeidler H, Brenner MH. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: a literature review. Semin Arthritis Rheum1997;25:771–9.
5. Ruchlin HS, Elkin EB, Paget SA. Assessing cost–effectiveness analyses in rheumatoid arthritis and osteoarthritis. Arthritis Care Res1997;10:413–22.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献